How to Handle Analyte Instability in Stored Samples – CAPA and Risk Mitigation
How to Handle Analyte Instability in Stored Samples – CAPA and Risk Mitigation Managing Analyte Instability in Stored Clinical Trial Samples: A CAPA-Focused Approach Introduction: The Criticality of Analyte Stability in Clinical Trials Bioanalytical sample integrity is vital to the success of clinical trials, particularly when evaluating pharmacokinetics, drug efficacy, or biomarker data. Analyte instability—defined…
Read More “How to Handle Analyte Instability in Stored Samples – CAPA and Risk Mitigation” »